The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
117344226 11734422 6 F 20160915 20151113 20160927 EXP PHEH2015US023443 SANDOZ 0.00 F Y 0.00000 20160927 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
117344226 11734422 1 SS ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Transplacental D 0
117344226 11734422 2 PS ONDANSETRON ONDANSETRON 1 Transplacental MOTHER'S DOSE: 4 MG 1 TO 2 TIMES A DAY D 77517
117344226 11734422 3 SS ONDANSETRON ONDANSETRON 1 Transplacental MOTHER'S DOSE: 4 MG 1 TO 2 TIMES A DAY D 0
117344226 11734422 4 SS ONDANSETRON DR REDDY ONDANSETRON 1 Transplacental MOTHER'S DOSE: 4 MG 1 TO 2 TIMES A DAY D 0
117344226 11734422 5 SS ONDANSETRON AUROBINDO ONDANSETRON HYDROCHLORIDE 1 Transplacental MOTHER'S DOSE: 4 MG 1 TO 2 TIMES A DAY D 0
117344226 11734422 6 SS ONDANSETRONE RANBAXY ONDANSETRON HYDROCHLORIDE 1 Transplacental MOTHER'S DOSE: 4 MG 1 TO 2 TIMES A DAY D 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
117344226 11734422 1 Foetal exposure during pregnancy
117344226 11734422 2 Foetal exposure during pregnancy
117344226 11734422 3 Foetal exposure during pregnancy
117344226 11734422 4 Foetal exposure during pregnancy
117344226 11734422 5 Foetal exposure during pregnancy
117344226 11734422 6 Foetal exposure during pregnancy

Outcome of event

Event ID CASEID OUTC COD
117344226 11734422 OT
117344226 11734422 CA

Reactions reported

Event ID CASEID DRUG REC ACT PT
117344226 11734422 Anhedonia
117344226 11734422 Anxiety
117344226 11734422 Atrial septal defect
117344226 11734422 Cleft palate
117344226 11734422 Congenital anomaly
117344226 11734422 Emotional distress
117344226 11734422 Foetal exposure during pregnancy
117344226 11734422 Gastrooesophageal reflux disease
117344226 11734422 Hyperkalaemia
117344226 11734422 Injury
117344226 11734422 Laryngomalacia
117344226 11734422 Micrognathia
117344226 11734422 Multiple congenital abnormalities
117344226 11734422 Pain
117344226 11734422 Pierre Robin syndrome
117344226 11734422 Renal failure
117344226 11734422 Renal hypertension

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found